Bakker Juliet Tammenoms's Net Worth

$533 Million

Estimate Recalculated Feb 23, 2024 08:58PM EST

Who is Bakker Juliet Tammenoms?

Bakker Juliet Tammenoms has an estimated net worth of $533 Million. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS INC, COLLEGIUM PHARMACEUTICAL, INC, Esperion Therapeutics, Inc., Inozyme Pharma, Inc., Lexeo Therapeutics, Inc., Axonics Modulation Technologies, Inc., Vera Therapeutics, Inc., RAPID MICRO BIOSYSTEMS, INC., RxSight, Inc., Tricida, Inc., Talaris Therapeutics, Inc., Sierra Oncology, Inc., Vaxcyte, Inc., 89bio, Inc., Eargo, Inc., Kala Pharmaceuticals, Inc., Venus Concept Inc., Molecular Templates, Inc., Aptinyx Inc., and Aimmune Therapeutics, Inc..

SEC CIK

Bakker Juliet Tammenoms's CIK is 0001431159

Past Insider Trading and Trends

2021 was Bakker Juliet Tammenoms's most active year for acquiring shares with 18 total transactions. Bakker Juliet Tammenoms's most active month to acquire stocks was the month of October. 2014 was Bakker Juliet Tammenoms's most active year for disposing of shares, totalling 26 transactions. Bakker Juliet Tammenoms's most active month to dispose stocks was the month of October. 2023 saw Bakker Juliet Tammenoms paying a total of $22,999,990.00 for 4,838,358 shares, this is the most they've acquired in one year. In 2022 Bakker Juliet Tammenoms cashed out on 3,616,896 shares for a total of $19,498,050.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Inozyme Pharma, Inc. (INZY) Snapshot price: $5.385

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+48.06%
1.35M
$3.69
$4,999,950.00
4.17M
Apr 19
Form 4
2.82M
$16.00
2.82M
Jul 28
Form 3
0
0
No matching records found

Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $16.92

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.57M
$11.00
2.57M
Nov 7
Form 3
0
0
No matching records found

RAPID MICRO BIOSYSTEMS, INC. (RPID) Snapshot price: $0.935

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5,466.78%
3.49M
$20.00
$3,000,000.00
3.56M
Jul 19
Form 3
0
0
No matching records found

COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.26

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-30.10%
-1.00M
$17.34
-$17,340,000.00
2.32M
Dec 8
Form 4
3.32M
$12.00
3.32M
May 12
Form 3
0
0
No matching records found

Tricida, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+104.56%
3.02M
$19.00
$2,500,001.00
5.91M
Jul 2
Form 3
0
0
No matching records found